ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
0.038
0.001
(2.70%)
Closed January 04 12:00AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.038
Bid
0.037
Ask
0.039
Volume
911,834
0.036 Day's Range 0.038
0.034 52 Week Range 0.1725
Market Cap
Previous Close
0.037
Open
0.036
Last Trade
15624
@
0.038
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
871,135
Shares Outstanding
685,229,436
Dividend Yield
-
PE Ratio
-2.08
Earnings Per Share (EPS)
-0.02
Revenue
32k
Net Profit
-13.18M

About Genmin Limited

Sector
Metal Mining Services
Industry
Metal Mining Services
Website
Headquarters
Perth, Western Australia, Aus
Founded
-
Genmin Limited is listed in the Metal Mining Services sector of the Australian Stock Exchange with ticker GEN. The last closing price for Genmin was AUD0.04. Over the last year, Genmin shares have traded in a share price range of AUD 0.034 to AUD 0.1725.

Genmin currently has 685,229,436 shares outstanding. The market capitalization of Genmin is AUD25.35 million. Genmin has a price to earnings ratio (PE ratio) of -2.08.

GEN Latest News

Genmab Files IND for HuMax-TF-ADC

Company Announcement IND for HuMax(R)-TF-ADC submitted to FDA Genmab's first IND submission for antibody-drug conjugate (ADC) product Patient enrolment in clinical trial expected...

Genentech and Biogen Idec Refused a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Company Announcement Genentech and Biogen Idec refused re-hearing in Arzerra patent infringement case COPENHAGEN, Denmark, July 15, 2013 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN...

Genmab Collaborator GSK Starts New Ofatumumab Phase III Study in Rare Skin Disorder

Company Announcement First Phase III study with subcutaneous formulation of ofatumumab Ofatumumab to be investigated in new autoimmune area - pemphigus vulgaris Patient...

Genmab and ADC Therapeutics Enter Co-Development Collaboration for an Antibody-Drug Conjugate Combining HuMax-TAC and PBD Warhe

Media Release     Antibody-drug conjugate (ADC) to be developed for cancer Combines strength of HuMax(R)-TAC with next generation PBD-based warhead technology 50:50 partnership ...

Teprotumumab Restarts Clinical Development in New Indication

Company Announcement Teprotumumab (RG1507) to be investigated for new indication River Vision Development Corporation to conduct clinical development under a license from Roche...

Genmab Launches Sponsored Level 1 American Depositary Receipt (ADR) Program

Company Announcement Genmab establishes Sponsored Level 1 ADR program Genmab ADRs can be traded on US over-the-counter (OTC) market effective today ADR ticker symbol GMXAY...

GSK and Genmab Announce Positive Top-Line Results From Pivotal Study of ARZERRA(R) (ofatumumab) Combined With Chlorambucil in P

Company Announcement Median 22.4 month progression free survival in patients treated with ofatumumab plus chlorambucil, an improvement of 9.3 months compared to chlorambucil alone No...

Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Company Announcement Genentech and Biogen Idec have filed for re-hearing in the United States COPENHAGEN, Denmark, May 17, 2013 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN) announced...

Genmab Announces Financial Results for the First Quarter of 2013

COPENHAGEN, Denmark, May 7, 2013 (GLOBE NEWSWIRE) -- Interim Report First Quarter 2013 Arzerra(r) received approval in Japan Arzerra net sales increased 65% over Q1...

Genmab Announces Top-Line Phase II Results for Ofatumumab Combined With Bendamustine in Untreated and Relapsed Chronic Lymphocy

Company Announcement 95% overall response rate and 43% complete response rate in patients with previously untreated chronic lymphocytic leukemia 74% overall response rate and 11...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.0380.0410.0363311150.0395119DE
4-0.005-11.62790697670.0430.0480.0365464510.0435468DE
12-0.016-29.62962962960.0540.0540.0348711350.04475714DE
26-0.087-69.60.1250.150.0345906060.05720435DE
52-0.062-620.10.17250.0347483290.08299173DE
156-0.182-82.72727272730.220.280.0343675570.11866693DE
260-0.282-88.1250.320.340.0343888340.16141285DE

GEN - Frequently Asked Questions (FAQ)

What is the current Genmin share price?
The current share price of Genmin is AUD 0.038
How many Genmin shares are in issue?
Genmin has 685,229,436 shares in issue
What is the market cap of Genmin?
The market capitalisation of Genmin is AUD 25.35M
What is the 1 year trading range for Genmin share price?
Genmin has traded in the range of AUD 0.034 to AUD 0.1725 during the past year
What is the PE ratio of Genmin?
The price to earnings ratio of Genmin is -2.08
What is the reporting currency for Genmin?
Genmin reports financial results in AUD
What is the latest annual turnover for Genmin?
The latest annual turnover of Genmin is AUD 32k
What is the latest annual profit for Genmin?
The latest annual profit of Genmin is AUD -13.18M
What is the registered address of Genmin?
The registered address for Genmin is LONDON HOUSE, SUITE 3 LEVEL 8, 216 ST GEORGES TERRACE, PERTH, WESTERN AUSTRALIA, 6000
What is the Genmin website address?
The website address for Genmin is genmingroup.com
Which industry sector does Genmin operate in?
Genmin operates in the METAL MINING SERVICES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
IBGIronbark Zinc Limited
AUD 0.255
(8,400.00%)
113.37k
KATOKatana Capital
AUD 0.003
(200.00%)
77.1k
TTMOTitan Minerals Limited
AUD 0.03
(87.50%)
12.33k
EELENRG Elements Ltd
AUD 0.0015
(50.00%)
10M
CCOOAThe Calmer Co International Ltd
AUD 0.0015
(50.00%)
2.21M
NRZONeuRizer Ltd
AUD 0.001
(-50.00%)
1.01M
EATEntertainment Rewards Ltd
AUD 0.002
(-50.00%)
968.35k
NACONAOS Ex50 Opportunities Company Limited
AUD 0.002
(-33.33%)
13.37k
PNTOAPanther Metals Ltd
AUD 0.002
(-33.33%)
47k
KNBOKoonenberry gold Ltd
AUD 0.005
(-28.57%)
1.63M
GCMGreen Critical Minerals Ltd
AUD 0.019
(5.56%)
117.1M
ROGRed Sky Energy Limited
AUD 0.009
(-14.29%)
74.61M
IMUImugene Limited
AUD 0.039
(4.00%)
46.15M
BRNBrainchip Holdings Ltd
AUD 0.415
(-4.05%)
35.04M
TMGTrigg Minerals Ltd
AUD 0.045
(4.65%)
28.2M

Discussion

View Full Feed
martyDg martyDg 2 minutes ago
Does he still remember his name?
NWBO
MasterBlastr MasterBlastr 2 minutes ago
No bid support . . . not enough believers.
GDVM
frrol frrol 3 minutes ago
Missling said such changes were done in the OLE. I too will be looking for that.
AVXL
TheHound TheHound 4 minutes ago
Kind of like watching paint dry when bitcoin dominance is neutral for the day.
XRPUSD
Stern is Bald Stern is Bald 4 minutes ago
Do your own research 
FNMA
DCBill DCBill 4 minutes ago
It has a "Paywall," i.e. pay the owner and you get it.
The FBI got in but was not invited.
FNMA
martyDg martyDg 4 minutes ago
Longs have been talking about the dire future for the short side since 2016, and up until now, that future still hasn't materialized. And that dire situation you're referring to is on the longs' side, since the stock price is currently at $0.27. You guys overuse the word 'future' indefinitely. Somet
NWBO
Kimbrown Kimbrown 4 minutes ago
Are you saying Ackman is a loser or you are a loser?
FNMA
frrol frrol 5 minutes ago
Missling's spinning is unfortunate, and counter-productive, and I suspect the same as you wrote regarding the journals. "ADL OR endpoint success" would not have passed any credible peer review. It didn't fool investors.
In addition to the EMA interest, the biomarker/MRI data and new endpoint
AVXL
cjstocksup cjstocksup 6 minutes ago
https://x.com/elonmusk/status/1875583435710066836
mattymatt66 mattymatt66 6 minutes ago
AB- we haven't sold our tech yet in any meaningful way. This is more relevant for a TAM when you actually succeed in selling your product- which we haven't yet.  I remain hopeful and optimistic, but we should/will/better know a lot more on 1/9. 
LWLG
EternalPatience EternalPatience 6 minutes ago
Short answer :  you will be fine

Log answer : no one knows the exact terms of  dilution or exit plans, date or capital buffer etc but you will be fine 
FNMA
TheHound TheHound 6 minutes ago
Not I. Bought on the way down. Tail end of a bullish flag. I’m all in.
XRPUSD
ChannelTrader ChannelTrader 6 minutes ago
Biden to Ban Oil, Gas Leases for 20 Years in Nevada, Weeks Before Trump Takes Office

https://truthpress.com/news/biden-to-ban-oil-gas-leases-for-20-years-in-nevada-weeks-before-trump-takes-office/?utm_source=truthpress.beehiiv.com&utm_medium=newsletter&utm_campaign=biden-to-ban-oil&_b
cjstocksup cjstocksup 6 minutes ago
This actually happened multiple times
https://x.com/elonmusk/status/1875585562025001005
jimr1717 jimr1717 7 minutes ago
Idiot
SAVEQ
mankind mankind 8 minutes ago
Speechless.....
SuperLogisticsMan SuperLogisticsMan 8 minutes ago
Geez, am I the only one following and holding this stock? $DRSHF
DRSHF
Hoskuld Hoskuld 8 minutes ago
It is 12 months from submission Sab. They aim for a 10 month review after an initial 60 day period. The statutory date is 12mo from submission and they rarely deviated from that exact date. I can only think of one application that was earlier that 12 months in my experience (30 years of exclusive
AVXL
FFFacts FFFacts 8 minutes ago
Tell that to the corrupt mods and admins. They love to act like a wanna be sherriff cause they got nothing else to be proud of in their loser lives.
FNMA
weedtrader420 weedtrader420 9 minutes ago
Anybody buying?
XRPUSD
sharkey1 sharkey1 9 minutes ago
Teva stock is going through the roof, I remember just last year, could have bought it at 8 bucks

https://finance.yahoo.com/quote/TEVA/


don't make me feel guilty
TEVA
cjstocksup cjstocksup 9 minutes ago
At this rate, the UK Government will pretty soon be executing people for liking a meme!
https://x.com/elonmusk/status/1875607203899715830
🚨🇬🇧UK ARRESTS SKYROCKET FOR SOCIAL MEDIA POSTS IN 2024: FREE SPEECH UNDER FIRE

In 2024, the UK arrested over
SuperLogisticsMan SuperLogisticsMan 9 minutes ago
It was a good week, especially yesterday. I even managed to pick up a few more shares. 😀

Go $CYBL

CYBL